Trial Profile
Effect of Evacetrapib on the Pharmacokinetics of Pravastatin in Healthy Japanese and Non-Japanese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs Evacetrapib (Primary) ; Pravastatin
- Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 23 Mar 2015 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-002935-12)
- 29 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Oct 2013 New trial record